Drug Information Analysis Service

Ostergaard K Dupont E . Clozapine treatment of drug induced psychotic symptoms in late stages of Parkinson's disease. Acta Neurol Scand 1988; 78: 349–50.

Friedman JH Lannon MC . Clozapine in the treatment of psychosis in Parkinson's disease. Neurology 1989; 39: 1219–21.

Wolters EC Hurwitz TA Mak E Teal P Peppard FR Remick R . Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis. Neurology 1990; 40: 832–4.

Bernardi F Del Zompo M . Clozapine in idiopathic Parkinson's disease (letter). Neurology 1990; 40: 1151–2.

Friedman JH Lannon MC . Clozapine-responsive tremor in Parkinson's disease. Mov Disord 1990; 5: 225–9.

Pakkenberg H Pakkenberg B . Clozapine in the treatment of tremor. Acta Neurol Scand 1986; 73: 295–7.

Opie LH . Calcium channel antagonists. Part I: Fundamental properties: Mechanisms, classification, sites of action. Cardiovasc Drugs Ther 1987; 1: 411–30.

Frishman W Charlap S Kimmel B Teichier M Cinnamon J Allen L . Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: Effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. Circulation 1988; 77: 774–86.

Prida XE Gelman JS Feldman RL Hill JA Pepine CJ Scott E . Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasm. J Am Coll Cardiol 1987; 9: 412–8.

Toyosaki N Toyo-Oka T Natsume T Katsuki T Tateishi T Yaginuma T . Combination therapy with diltiazem and nifedipine in patients with effort angina pectoris. Circulation 1988; 77: 1370–5.

Kasemeyer WH Prisant LM Carr AA . Verapamil and nifedipine in combination for the treatment of hypertensive heart disease. Am J Hypertens 1991; 4: 866–7.

Busse JC DeVelasco RE Pellegrini EL . Combined use of nifedipine and diltiazem for the treatment of severe hypertension. South Med J 1991; 84: 502–4.

Long WF Taylor RJ Wagner CJ Leavengood DC Nelson HS . Skin test suppression by antihistamines and the development of subsensitivity. J Allergy Clin Immunol 1985; 76: 113–7.

Antihistamines (systemic). In: USP DI drug information for the health care professional. Vol. IA. 12th ed. Rockville, MD: The United States Pharmacopeial Convention, 1992: 393–413.

Almind M Dirksen A Nielsen NH Svendsen UG . Duration of the inhibitory activity on histamine-induced skin weals of sedative and non-sedative antihistamines. Allergy 1988; 43: 593–6.

Heykants J Van Peer A Woestenborghs R Jageneau A Vanden Bussche G . Dose-proportionality, bioavailability, and steady-state kinetics of astemizole in man. Drug Dev Res 1986; 8: 71–8.

Krstenansky PM Cluxton RJ Jr . Astemizole: A long-acting, nonsedating antihistamine. Drug Intell Clin Pharm 1987; 21: 947–53.

Laduron PM Janssen PFM Gommeren W Leysen JE . In vitro and in vivo binding characteristics of a new long-acting histamine H₁ antagonist, astemizole. Mol Pharmacol 1982; 21: 294–300.

Simons FER McMillan JL Simons KJ . A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990; 86: 540–7.

Bateman DN Chapman PH Rawlins MD . The effects of astemizole on histamine-induced weal and flare. Eur J Clin Pharmacol 1983; 25: 547–51.

Filderman RB . Inhibition of skin reactivity by antihistamines. Cutis 1988; 42: 19–21.

Filderman RB Rosen LJ . Comparison of onset and offset of inhibition of antigen-induced skin whealing of Seldane (terfenadine), Hismanal (astemizole) and placebo (abstract). J Allergy Clin Immunol 1987; 79: 190.

Lantin JP Huguenot C Pecoud AR . Effect of astemizole on skin tests with histamine, codeine and allergens (abstract). J Allergy Clin Immunol 1988; 81: 175.

Howarth PH Emanuel MB Holgate ST . Astemizole, a potent histamine H₁-receptor antagonist: Effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels. Br J Clin Pharmacol 1984; 18: 1–8.

Wyse DM, Kitchener [no initials provided]. Astemizole: Prolonged suppression of skin tests to ragweed and histamine in ragweed-sensitive patients (abstract). Clin Invest Med 1987; 10 (4 suppl B):B48.

Davies R Brook M Griffiths J . Skin test recovery after astemizole therapy (abstract). Rev Esp Alergol Inmunol Clin 1987; 2: 79.

Tyolahti H Lahti A . Start and end of the effects of terfenadine and astemizole on histamine-induced wheals in human skin. Acta Derm Venereol (Stockholm) 1989; 69: 269–71.